Statistics for Zomedica Pharmaceuticals (id:169 ZOM)
Valuation metrics
Market cap
117.59M
Enterprise value
42.04M
Trailing P/E (ttm)
-3.57
Forward P/E
-14.59
PEG ratio
5.00
Price/Sales (ttm)
4.51
Price/Book (mrq)
3.00
Enterprise Value/Revenue
1.61
Enterprise Value/EBITDA
-1.43
Overview
Shares outstanding
979.95M
Float
961.51M
Shares short
51.14M
% Held by insiders
5.00%
% Held by institutions
5.00%
Average volume (10 days)
4.68M
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
3.00
52-Week change
-77.60%
Beta
1.06
50-Day moving average
3.00
200-Day moving average
3.00
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-214.70%
Operating margin
-147.50%
Operational effectiveness
Return on assets
-9.29%
Return on equity
-23.92%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
17.32M
EBITDA
-29,393,000.00
Net income to common (ttm)
-55,986,000.00
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
10.24%
Balance sheet
Total cash (mrq)
79.51M
Total cash per share (mrq)
5.00
Total debt (mrq)
2.29M
Total Debt/Equity (mrq)
1.10
Current ratio (mrq)
1.14K%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-22,351,000.00
Levered free cash flow (LFCF)
-23,166,750.00